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We evaluated the effect of frequent, early bolus administration of low-dose 
sodium bicarbonate (NaHCO3) on blood gas values during ventricular 
fibrillation and cardiopulmonary resuscitation (CPR) compared with normal 
saline and standard bolus doses of NaHCO3. This was a randomized laboratory 
investigation involving 13 mongrel dogs and 18 experiments (5 dogs were used 
in a crossover manner). Each dog underwent 3 minutes of ventricular 
fibrillation, followed by 15 minutes of CPR. Animals were randomly assigned to 
one of three treatments administered early in the resuscitation effort: NaHCO3 
0.5 mEq/kg at 5 ,  10, and 15 minutes of ventricular fibrillation (SB); NaHC03 1 
mEq/kg at 5 minutes and 0.5 mEq/kg at 15 minutes of fibrillation (B); or 0.9% 
NaCl 1 mVkg at 5 minutes and 0.5 mlkg at 15 minutes of fibrillation (P). A 
total of 15 experiments were included for analysis. Arterial and venous blood 
gases were sampled at 4, 8, 13, and 18 minutes of fibrillation. The SB group 
demonstrated the highest arterial partial pressures of carbon dioxide (pC02) at 
each sampling point after NaHCO3, including the 18-minute sample: 42 * 12, 
29 k 11, and 35 * 10 torr for SB, P, and B, respectively. In addition, SB produced 
arterial alkalemia (pH > 7.45) after NaHCO3 administration. The arterial pH at 
18 minutes of fibrillation for SB, P, and B was 7.46 * 0.14, 7.29 f 0.07, and 7.41 
* 0.1, respectively. Similar trends for pC02 and pH were observed for venous 
samples. Early, frequent administration of low-dose NaHC03 during CPR is 
associated with elevated p C 0 ~  and pH (alkalotic) values that may be potentially 
detrimental in this setting. It appears that this mode of administration offers no 
advantage over B with regard to blood gas values during CPR in this canine 
model. 
(Pharmacotherapy 1994; 14( 1 ):95-99) 
During cardiac arrest and cardiopulmonary 
resuscitation (CPR), acidemia develops as a result 
of decreased oxygen delivery to the tissues, which 
leads to lactate production from anaerobic 
metabolism and tissue acidosis. The accumulation 
of lactate and the increased carbon dioxide 
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concentrations contribute to the metabolic and 
respiratory acidemia. 
Potential complications of profound acidemia 
during CPR are depressed myocardial contractility, 
a lowered ventricular fibrillation threshold, an 
increased ventricular defibrillation threshold, and 
attenuation of catecholamine effectiveness. le6 The 
current treatment of systemic acidemia that is not 
corrected by adequate ventilation is intravenous 
bolus injection of sodium bicarbonate (NaHCO3) 1 
mEq/kg followed every 10  minutes by 0.5 
mEq/kg.7 However, complications associated with 
standard bolus doses of NaHCO3 include 
hypercarbia, intracellular acidosis, and alkalemia. 
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What is not known is whether or not these 
complications may be attenuated by altering both 
the timing and the method of drug delivery. 
Standard administration of NaHCO3 results in a 
high concentration of drug in an environment 
containing high concentrations of hydrogen ions, 
which results in alkalemia and increases partial 
pressure of carbon dioxide (pC02). This may 
potentially be avoided by administering small, 
frequent, bolus doses early in the resuscitation 
period. This may allow NaHC03 to counteract the 
increase in hydrogen ions when concentrations are 
lower without overwhelming the system, and may 
avoid the need for large doses later. In addition, 
early administration of small doses may attenuate 
the increase in pC02 and allow the excess to be 
eliminated by ventilation. Therefore, we attempted 
to determine if an alternative mode of NaHC03 
administration (small frequent doses early during 
resuscitation) has beneficial effects on blood gas 
values. 
Materials and Methods 
Thirteen dogs that had previously undergone an 
episode of cardiac arrest with CPR were evaluated 
in a randomized fashion (random numbers in 
blocks of 3). Data analysis was performed in a 
blinded manner. The study was approved by the 
Unit for Laboratory Animal Medicine. 
Before instrumentation, a forelimb vein was 
cannulated and surgical anesthesia was produced 
by intravenous injection of pentobarbital 25 
mg/kg. The depth of anesthesia was routinely 
assessed, and supplemental pentobarbital 5 mgkg 
was administered every 30 minutes as required. 
Each dog was secured in a supine position on a 
surgical table with a thermoblanket to maintain a 
body temperature of 37°C. 
A cuffed endotracheal tube was placed, with 
respirations controlled by an Ohio Anesthesia 
Ventilator (Ohio Medical Products, Madison, WI) 
with a fraction of inspired oxygen (fi02) of 1.0. 
Respirations were initiated at a rate of 1 5  
breathdminute with a tidal volume of 15 mVkg. 
The ventilatory rate and tidal volume were 
adjusted to achieve and maintain an arterial pH of 
7.40 +_ 0.05 and a pC02 of 40 +_ 5 torr. 
Blood samples were analyzed using a Radiometer 
ABL2 (Acid-Base Laboratory, Cleveland, OH) 
within 5 minutes of sampling. Samples not 
immediately analyzed were stored in ice and 
analyzed within 30 minutes. Arterial (aortic) 
samples were collected through a pigtail catheter 
inserted into the femoral artery and positioned 
with its tip in the aortic arch. Venous blood 
samples were collected through a 6F catheter 
inserted into the right jugular vein and positioned 
with its tip in the right atrium. 
Aortic and right atrial pressures were measured 
through the pigtail catheters. All pressures were 
measured with a Gould P23 pressure transducer 
(after calibration), displayed on a monitor, and 
recorded by a Gould 8-channel RS 3800 graphic 
recorder (Gould Inc. ,  Cleveland, OH). The 
position of each catheter was determined by 
evaluating the pressure waveform and confirmedeat 
the end of the experiment by autopsy. After 
catheter placement all dogs were anticoagulated 
with intravenous heparin 150 U/kg to ensure 
catheter patency. A three-lead surface 
electrocardiogram (EGG) was also continuously 
monitored and recorded. 
After stabilization of arterial pH and pCOz, 
ventricular fibrillation was induced using a pacing 
wire carrying a 24-mA, 60-Hz electrical cur rb t  
placed through a 6F catheter with its tip in the 
right ventricle. Ventricular fibrillation was 
confirmed by ECG pattern and loss of arterial 
pressures. After 3 minutes of unassisted cardiac 
arrest, CPR was begun using a pneumatic chest 
compression device (Thumper;  Michigan 
Instruments,  Grand Rapids, MI) set at a 
compression rate of 80/minute with a compression 
duration of 0.5 seconds. The compression force 
was adjusted to produce a ,coronary perfusion 
pressure gradient (aortic-right atrial middiastolic 
pressure) of approximately 20 mm Hg. After every 
fifth compression, diastole was prolonged by 0.5 
seconds and the lungs were inflated with an 
inspiratory pressure setting of approximately 10 
cm H2O and f i 0 2  of 1.0. 
After 5 minutes of ventricular fibrillation (2 min 
CPR), the animals were randomly assigned to one 
of three treatment groups: NaHC03 1 mEq/kg 
intravenous bolus over 20 seconds, followed by a 
second 0.5-mEqkg bolus given at 15 minutes of 
ventricular fibrillation (B); NaHC03 0.5 mEq/kg 
intravenous bolus over 20 seconds, followed by a 
0.5-mEq/kg bolus at 10  and 1 5  minutes of 
ventricular fibrillation (SB); or 0.9% NaCl 1 mVkg 
intravenous bolus over 20 seconds, followed by a 
second bolus of 0.5 m a g  given at 15 minutes of 
ventricular fibrillation (P). All treatments were 
administered through an indwelling catheter in a 
forelimb vein. At 4, 8, 13, and 18 minutes O t  
cardiac arrest, blood samples were simultaneously 
obtained from the aorta and right atrium to 
determine blood gas values. 
Statistical analysis was performed using analyss 
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Table 1.  Blood Gases Before and During CPR 
Time Treatment G r o w  
(min) B SB P B SB P 
0 
4 
8 
13 
18 
0 
4 
8 
13 
18 
0 
4 
8 
13 
18 
PHa 
7.372 c 0.019 7.400 i 0.034 7.388 * 0.027 
7.446 c 0.058 7.476 * 0.112 7.416 c 0.040 
7.506 c 0.205 7.498 * 0.156 7.390 * 0.077 
7.408 * 0.143 7.466 f 0.150 7.366 * 0.067 
7.408 c 0.104 7.466 f 0.145 7.295 i 0.071 
aPCOL (torr) 
40.10 f 3.904 37.62 * 2.410 39.24 * 3.008 
29.18 c 5.206 28.02 c 8.679 30.48 * 5.528 
35.90 * 12.723 36.50 * 8.858 26.32 i 10.495 
30.78 * 12.479 37.02 * 10.735 27.60 i 8.660 
34.62 c 10.084 42.10 * 11.653 29.05 * 11.181 
aHCO3 (mEq/L) 
22.78 -e 1.678 22.98 i 2.956 23.20 * 2.027 
19.62 i 2.273 20.04 i 4.014 19.14 * 1.674 
28.22 i 9.318 27.82 * 6.672 15.22 i 4.200" 
18.20 c 3.947 25.88 * 4.655b 15.20 c 3.585 
20.86 i 2.456 27.20 * 3.132 13.88 i 5.432a 
PHV 
7.334 i 0.025 7.342 2 0.026 7.350 * 0.034 
7.262 i 0.019 7.307 f 0.058 7.300 * 0.033 
7.278 c 0.081 7.270 i 0.037 7.242 * 0.072 
7.246 f 0.071 7.240 f 0.042 7.224 * 0.072 
7.227 + 0.042 7.232 c 0.056 7.200 * 0.071 
vPC07 (torr) 
43.58 * 6.445 
55.68 * 5.048 
64.84 i 15.457 
64.06 f 12.522 
65.85 i 9.764 
22.54 * 2.458 
23.62 * 1.886 
29.00 * 3.833 
26.46 * 1.923 
26.38 c 1.348 
48.58 i 4.342 
52.72 i 9.077 
68.60 * 5.680 
72.45 i 7.233 
74.02 i 5.874 
46.42 * 7.443 
52.82 * 6.272 
54.14 * 15.847 
55.28 * 14.036 
59.94 * 12.681 
v H C O ~  (mEq/L) 
25.75 * 3.472 24.92 i 3.200 
24.07 c 4.881 
30.82 c 3.657 
29.88 i 2.546 
30.08 * 2.022 
25.22 t 2.587 
21.86 * 3.684" 
21.60 * 3,004" 
22.32 * 2.298' 
'pp<O.O5, P versus B and SB. 
bp<O 05 ,  SB versus B and F1 
of variance (ANOVA) with a repeated measures 
design. Differences among means were evaluated 
using Tukey's Studentized range test with a ~ ~ 0 . 0 5  
considered significant. Data are reported as means 
* SD. 
Results 
Data suitable for analysis were obtained from 15 
drug trials (experiments) in the 13 animals. Prior 
to breaking the randomization code, data from one 
trial in each of the treatment groups were excluded 
from analysis because of a decreased baseline aortic 
oxygen saturation greater than 2 SD from the 
population mean. Since all animals had a prior 
episode of cardiac arrest and CPR of similar 
duration (10 min), a decrease in aortic oxygen 
saturation could be an indication of underlying 
pathology, and therefore data from these animals 
were excluded. Five animals were evaluated in a 
crossover fashion, having been randomized to a 
different treatment arm after successful 
resuscitation. These were the only animals that 
were successfully resuscitated after NaHCO3 
administration. 
In addition to baseline blood gas values, baseline 
and CPR hemodynamics were evaluated to ensure 
that the animals were comparable among groups. 
No significant differences were seen in baseline 
arterial systolic or diastolic pressures among the 
three groups: B 122 * 30 mm Hg (range 80-160 
mm Hg) and 89 * 30 mm Hg (range 60-130 mm 
Hg); SB 116 * 19 mm Hg (range 85-135 mm Hg) 
and 93 * 17 mm Hg (range 65-110 mm Hg); and 
P 99 38 mm Hg (range 50-135 mm Hg) and 80 
* 37 mm Hg (range 30-115 mm Hg; p>0.50). In 
addition, no significant difference was seen in 
coronary perfusion pressures after drug 
administration; a t  5 minutes of ventricular 
fibrillation for B, SB, and P they were 19 * 9, 23 * 
8, and 23 * 12 mm Hg, respectively (p>0.78). 
The mean arterial and right atrial pH, pC02, and 
HC03 measurements during CPR are shown in 
Table 1. There were no statistically significant 
differences in either pH or p C 0 ~  among groups at 
baseline or after 4, 8, 13, and 18 minutes of CPR. 
No significant difference in the arteriovenous pH 
gradient was detected; however, arterial alkalemia 
(pH > 7.45) occurred intermittently at times after 
drug administration in both NaHCO3 groups 
compared with arterial acidemia (pH < 7.35) in the 
P group. In addition, the SB group had the 
greatest elevation in pC02 values at all times 
measured after drug administration. 
Prior to inducing cardiac arrest and at 4 minutes 
of ventricular fibrillation, the arterial and venous 
bicarbonate concentrations in all groups were 
similar. After 8 minutes of ventricular fibrillation, 
both the arterial and venous concentrations were 
significantly higher in animals randomized to the B 
and SB groups compared with placebo (p<0.05). 
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After 13 minutes of ventricular fibrillation, the 
arterial bicarbonate level in the SB group remained 
significantly increased compared with the other 
two groups (p<0.05). However, in both B and SB 
groups it was again significantly increased above P 
at 18 minutes (p<0.05). 
Discussion 
Similar to results from other investigations, the 
current study demonstrated that systemic acidemia 
develops during CPR.'. To simulate CPR 
technique, aggressive ventilation was maintained, 
and the arterial pC02 decreased by approximately 
10 torr at 4 minutes in all groups. This degree of 
arterial hypocarbia was maintained in the placebo 
group until the end of the CPR period. However, 
after NaHC03 administration, it increased in both 
treatment groups, being highest in the SB group at 
the end of CPR (p>0.05). 
Despite the failure to demonstrate a statistically 
significant difference in pC02 among the groups, 
there appeared to be a trend to an overall higher 
value in  the NaHC03 groups,  as discussed 
previously. This result is not unexpected, since 
other studies reported significant increases in 
p C 0 2  after bicarbonate administration.". l1 
Similarly, we found no statistically significant 
differences in  pH values among the groups. 
However, arterial alkalemia did occur in both the B 
and SB groups after drug administration. A 
potential complication of this is enhanced 
glycolysis leading to increased lactic acid 
production and increased oxygen-hemoglobin 
binding. In addition, arterial alkalemia may result 
in  lower coronary perfusion pressures after 
epinephrine therapy, compared with art e r i a 1 
acidemia.12 
The guidelines for advanced cardiac life support 
promulgated by the American Heart Association do 
not support early, empiric administration of 
NaHCO3 during cardiopulmonary resu~citation.~ 
The rationale is that acidemia can be controlled by 
ventilation alone for a short period of time, and 
that NaHC03 may be detrimental and produce 
arterial alkalemia and paradoxic intracellular and 
intracerebral acidosis secondary to increased pC02. 
We observed no favorable effects for an alternative 
dosing method (SB group) on arterial or venous 
pH or pC02 when administered early during CPR. 
In fact, this method was associated with the 
greatest elevation in arterial pH and pCO2 at the 
end of CPR. 
With a larger sample these differences may have 
become significant (type 11 error). For example, to 
detect a difference in pC02, approximately seven 
more experiments would have to be done to detect 
a difference between placebo and SB (a=0.05, 
p=0.2). Therefore, several low-dose boluses of 
NaHC03 administered every 5 minutes early 
during CPR may be less desirable than the 
currently recommended method, secondary to 
increased pC02 concentrations and the 
development of alkalemia. 
In contrast to these results, another animal study 
suggested that alternative modes of NaHCO3 
administration may be beneficial. A continuous 
infusion of 0.1 mEq/kg/minute increased venous 
pH without significantly increasing pC02,  
compared with standard doses.* In addition, there 
was no indication of cerebrospinal fluid acidosis 
for the continuous-infusion group. Further work 
in this area is necessary to determine if alternative 
modes of NaHC03 administration may be 
beneficial during CPR. 
The findings of the current study should be 
interpreted with caution since the duration of 
ventricular fibrillation and CPR was short, and 
intracellular pH and survival were not evaluated. 
The relatively small sample may have hindered our 
ability to detect significant differences among the 
treatment groups. In addition, the sampling 
scheme may not have allowed for the detection of 
peak increases in pH and pC02, which may have 
demonstrated significant differences from the 
placebo group. Finally, the applicability of these 
results to humans during cardiopulmonary arrest is 
unknown. 
Our results demonstrate that early, frequent 
administration of low-dose NaHC03 during CPR is 
associated with elevated pC02 and pH (alkalotic) 
values that may be potentially detrimental in this 
setting. From these results it appears that this 
mode of administration offers no advantage over 
standard-dose NaHC03 as it relates to blood gas 
values during CPR in this canine model. Further 
studies will determine if alternate methods of 
NaHC03 administration for correcting acidemia 
during CPR are beneficial. 
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